rs28730837

This is a variant in the MPO gene that changes a alanine to an valine.

GWAS Catalog Trait Associations (8)

Genome-wide significant associations (p < 5×10⁻⁸) from the NHGRI-EBI GWAS Catalog.

basophil count

Vuckovic D et al. The Polygenic and Monogenic Basis of Blood Traits and Diseases. Cell 182(5):1214-1231.e11 (2020)
Allele A
OR 0.10
p 3.0e-30
N 408,112
Large GWAS
European
Allele A
OR 0.06
p 2.0e-10
N 404,717
Large GWAS
European
Kachuri L et al. Genetic determinants of blood-cell traits influence susceptibility to childhood acute lymphoblastic leukemia. American Journal of Human Genetics 108(10):1823-1835 (2021)
Allele A
OR
p 6.0e-10
N 234,678
Large GWAS
European

myeloblastin measurement

Allele A
OR 0.21
p 4.0e-27
N 47,745
Large GWAS
European

basophil percentage of leukocytes

Vuckovic D et al. The Polygenic and Monogenic Basis of Blood Traits and Diseases. Cell 182(5):1214-1231.e11 (2020)
Allele A
OR 0.09
p 5.0e-26
N 408,112
Large GWAS
European
Allele A
OR 0.06
p 1.0e-12
N 404,531
Large GWAS
European

monocyte count

Kachuri L et al. Genetic determinants of blood-cell traits influence susceptibility to childhood acute lymphoblastic leukemia. American Journal of Human Genetics 108(10):1823-1835 (2021)
Allele G
OR
p 1.0e-23
N 234,690
Large GWAS
European
Vuckovic D et al. The Polygenic and Monogenic Basis of Blood Traits and Diseases. Cell 182(5):1214-1231.e11 (2020)
Allele G
OR 0.06
p 2.0e-9
N 408,112
Large GWAS
European

monocyte percentage of leukocytes

Vuckovic D et al. The Polygenic and Monogenic Basis of Blood Traits and Diseases. Cell 182(5):1214-1231.e11 (2020)
Allele A
OR 0.09
p 3.0e-17
N 408,112
Large GWAS
European

neutrophil count

Allele A
OR 0.06
p 2.0e-13
N 394,642
Large GWAS
European

lymphocyte percentage of leukocytes

Vuckovic D et al. The Polygenic and Monogenic Basis of Blood Traits and Diseases. Cell 182(5):1214-1231.e11 (2020)
Allele A
OR 0.06
p 1.0e-12
N 408,112
Large GWAS
European

neutrophil percentage of leukocytes

Vuckovic D et al. The Polygenic and Monogenic Basis of Blood Traits and Diseases. Cell 182(5):1214-1231.e11 (2020)
Allele A
OR 0.06
p 2.0e-9
N 408,112
Large GWAS
European

ClinVar annotation

Pathogenic☆☆☆
5 submitters2 publications

Myeloperoxidase deficiency (MPOD)

View on ClinVar →

Research that mentions this SNP (1)

Genetic variants in TLR2 and TLR4 are associated with markers of monocyte activation: the Atherosclerosis Risk in Communities MRI Study
AssociationN=1,817Suzette J. Bielinski et al.(2011)· Human Genetics

This candidate gene study of 1,817 participants from the ARIC Carotid MRI cohort identified genetic variants associated with monocyte activation markers. TLR2 rs1816702 was associated with increased CD14+/TLR2+ monocyte levels in whites (p<0.001), while TLR4 rs5030719 was associated with CD14+/TLR4+ levels in blacks (p<0.001). MPO gene variants also showed modest associations with monocyte MPO levels, demonstrating population-specific genetic influences on immune cell surface receptor expression.

Traits studied:Monocyte CD14+/TLR2+ levelsMonocyte CD14+/TLR4+ levelsMonocyte MPO levelsMonocyte activation markers

About MPO

Myeloperoxidase (MPO) is a heme protein synthesized during myeloid differentiation that constitutes the major component of neutrophil azurophilic granules. Produced as a single chain precursor, myeloperoxidase is subsequently cleaved into a light and heavy chain. The mature myeloperoxidase is a tetramer composed of 2 light chains and 2 heavy chains. This enzyme produces hypohalous acids central to the microbicidal activity of neutrophils. [provided by RefSeq, Nov 2014]

View all MPO variants →

Gene information from NCBI Gene. Variant classifications from ClinVar.

Community Wiki

No community notes yet for this variant. Sign in to start one.

Comments

Sign in to join the discussion.

Loading comments…